| UniProt ID | MAK16_HUMAN | |
|---|---|---|
| UniProt AC | Q9BXY0 | |
| Protein Name | Protein MAK16 homolog | |
| Gene Name | MAK16 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 300 | |
| Subcellular Localization | Nucleus, nucleolus . | |
| Protein Description | ||
| Protein Sequence | MQSDDVIWDTLGNKQFCSFKIRTKTQSFCRNEYSLTGLCNRSSCPLANSQYATIKEEKGQCYLYMKVIERAAFPRRLWERVRLSKNYEKALEQIDENLIYWPRFIRHKCKQRFTKITQYLIRIRKLTLKRQRKLVPLSKKVERREKRREEKALIAAQLDNAIEKELLERLKQDTYGDIYNFPIHAFDKALEQQEAESDSSDTEEKDDDDDDEEDVGKREFVEDGEVDESDISDFEDMDKLDASSDEDQDGKSSSEEEEEKALSAKHKGKMPLRGPLQRKRAYVEIEYEQETEPVAKAKTT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MQSDDVIW -------CCCCCCEE | 8.53 | 22223895 | |
| 3 | Phosphorylation | -----MQSDDVIWDT -----CCCCCCEEEC | 34.18 | 21406692 | |
| 10 | Phosphorylation | SDDVIWDTLGNKQFC CCCCEEECCCCCEEE | 22.90 | 21406692 | |
| 20 | Acetylation | NKQFCSFKIRTKTQS CCEEEEEEEEECCCC | 18.25 | 26051181 | |
| 25 | Phosphorylation | SFKIRTKTQSFCRNE EEEEEECCCCHHCCC | 28.91 | 28450419 | |
| 27 | Phosphorylation | KIRTKTQSFCRNEYS EEEECCCCHHCCCCC | 31.39 | 30576142 | |
| 33 | Phosphorylation | QSFCRNEYSLTGLCN CCHHCCCCCCHHCCC | 16.72 | 25884760 | |
| 34 | Phosphorylation | SFCRNEYSLTGLCNR CHHCCCCCCHHCCCC | 17.18 | 28152594 | |
| 43 | Phosphorylation | TGLCNRSSCPLANSQ HHCCCCCCCCCCCCC | 19.27 | 28555341 | |
| 53 | Phosphorylation | LANSQYATIKEEKGQ CCCCCCEEEEECCCC | 27.87 | 22210691 | |
| 55 | Sumoylation | NSQYATIKEEKGQCY CCCCEEEEECCCCEE | 56.30 | 28112733 | |
| 55 | Ubiquitination | NSQYATIKEEKGQCY CCCCEEEEECCCCEE | 56.30 | 33845483 | |
| 55 | Acetylation | NSQYATIKEEKGQCY CCCCEEEEECCCCEE | 56.30 | 26051181 | |
| 62 | Phosphorylation | KEEKGQCYLYMKVIE EECCCCEEEEEEHHH | 7.93 | 22817900 | |
| 66 | Acetylation | GQCYLYMKVIERAAF CCEEEEEEHHHHHCC | 26.89 | 26051181 | |
| 100 | Phosphorylation | QIDENLIYWPRFIRH HHHHHHCHHHHHHHH | 16.72 | - | |
| 110 | Ubiquitination | RFIRHKCKQRFTKIT HHHHHHHHHHHHHHH | 49.68 | 22817900 | |
| 115 | Ubiquitination | KCKQRFTKITQYLIR HHHHHHHHHHHHHHH | 40.83 | 21890473 | |
| 115 | Ubiquitination | KCKQRFTKITQYLIR HHHHHHHHHHHHHHH | 40.83 | 22817900 | |
| 115 | Acetylation | KCKQRFTKITQYLIR HHHHHHHHHHHHHHH | 40.83 | 25953088 | |
| 117 | Phosphorylation | KQRFTKITQYLIRIR HHHHHHHHHHHHHHH | 16.84 | 21406692 | |
| 119 | Phosphorylation | RFTKITQYLIRIRKL HHHHHHHHHHHHHHH | 8.75 | 28152594 | |
| 127 | Phosphorylation | LIRIRKLTLKRQRKL HHHHHHHHHHCHHHH | 33.01 | 24719451 | |
| 138 | Phosphorylation | QRKLVPLSKKVERRE HHHHHCCHHHHHHHH | 25.10 | 24114839 | |
| 140 | Ubiquitination | KLVPLSKKVERREKR HHHCCHHHHHHHHHH | 46.05 | 24816145 | |
| 151 | 2-Hydroxyisobutyrylation | REKRREEKALIAAQL HHHHHHHHHHHHHHH | 43.68 | - | |
| 151 | Sumoylation | REKRREEKALIAAQL HHHHHHHHHHHHHHH | 43.68 | - | |
| 151 | Sumoylation | REKRREEKALIAAQL HHHHHHHHHHHHHHH | 43.68 | 28112733 | |
| 164 | Acetylation | QLDNAIEKELLERLK HHHHHHHHHHHHHHH | 47.77 | 26051181 | |
| 164 | Ubiquitination | QLDNAIEKELLERLK HHHHHHHHHHHHHHH | 47.77 | 29967540 | |
| 171 | Acetylation | KELLERLKQDTYGDI HHHHHHHHCCCCCHH | 52.96 | 26051181 | |
| 171 | Sumoylation | KELLERLKQDTYGDI HHHHHHHHCCCCCHH | 52.96 | - | |
| 171 | Ubiquitination | KELLERLKQDTYGDI HHHHHHHHCCCCCHH | 52.96 | 29967540 | |
| 171 | Sumoylation | KELLERLKQDTYGDI HHHHHHHHCCCCCHH | 52.96 | - | |
| 174 | Phosphorylation | LERLKQDTYGDIYNF HHHHHCCCCCHHHHC | 27.23 | 28152594 | |
| 175 | Phosphorylation | ERLKQDTYGDIYNFP HHHHCCCCCHHHHCH | 22.53 | 28152594 | |
| 179 | Phosphorylation | QDTYGDIYNFPIHAF CCCCCHHHHCHHHHH | 18.58 | 28152594 | |
| 197 | Phosphorylation | LEQQEAESDSSDTEE HHHHHHHCCCCCCCC | 50.25 | 23927012 | |
| 199 | Phosphorylation | QQEAESDSSDTEEKD HHHHHCCCCCCCCCC | 39.12 | 25159151 | |
| 200 | Phosphorylation | QEAESDSSDTEEKDD HHHHCCCCCCCCCCC | 54.25 | 23927012 | |
| 202 | Phosphorylation | AESDSSDTEEKDDDD HHCCCCCCCCCCCCC | 48.25 | 30278072 | |
| 229 | Phosphorylation | EDGEVDESDISDFED HCCCCCHHHCCCCCC | 35.46 | 26503892 | |
| 232 | Phosphorylation | EVDESDISDFEDMDK CCCHHHCCCCCCHHH | 41.03 | 26503892 | |
| 243 | Phosphorylation | DMDKLDASSDEDQDG CHHHCCCCCCCCCCC | 37.68 | 20363803 | |
| 244 | Phosphorylation | MDKLDASSDEDQDGK HHHCCCCCCCCCCCC | 46.90 | 20363803 | |
| 252 | Phosphorylation | DEDQDGKSSSEEEEE CCCCCCCCCCHHHHH | 44.63 | 20363803 | |
| 253 | Phosphorylation | EDQDGKSSSEEEEEK CCCCCCCCCHHHHHH | 45.30 | 20363803 | |
| 254 | Phosphorylation | DQDGKSSSEEEEEKA CCCCCCCCHHHHHHH | 57.00 | 20363803 | |
| 282 | Phosphorylation | PLQRKRAYVEIEYEQ CCCCCCEEEEEEEEE | 11.58 | 27642862 | |
| 287 | Phosphorylation | RAYVEIEYEQETEPV CEEEEEEEEECCCCC | 28.68 | 28796482 | |
| 291 | Phosphorylation | EIEYEQETEPVAKAK EEEEEECCCCCCCCC | 45.33 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MAK16_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MAK16_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MAK16_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-197 AND SER-200, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-197 AND SER-200, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197; SER-199; SER-200AND THR-202, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197; SER-200; SER-229AND SER-232, AND MASS SPECTROMETRY. | |